In the univariate analysis, higher p16INK4a mRNA expression in PBMCs was associated with 1.29-fold increased risk of breast cancer (OR = 1.29; 95%CI: 1.02, 2.72, p = 0.047). This evidence concerns the gene CDKN2A and breast cancer.